Raltegravir-based ART
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Raltegravir-based ART, covering 2024-11-20 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection [Phase 4]